Market Cap (In KRW)
215.42 Billion
Revenue (In KRW)
159.9 Billion
Net Income (In KRW)
-23.28 Billion
Avg. Volume
501.66 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3075.0-9400.0
- PE
- -
- EPS
- -
- Beta Value
- 1.009
- ISIN
- KR7092040005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Piao Zhe
- Employee Count
- -
- Website
- http://www.amicogen.com
- Ipo Date
- 2013-09-12
- Details
- Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, chemical, and energy industries. It also provides new bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides; and lactic acid bacteria, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. In addition, the company offers K-nutra, a healthcare brand; and KeyClean, a disinfectant brand. Further, it provides protein purification resins. The company was founded in 2000 and is headquartered in Jinju-si, South Korea.
More Stocks
-
CMXHFCSL Limited
CMXHF
-
EESE
-
JPM-PJJPMorgan Chase & Co.
JPM-PJ
-
PAL
-
1618
-
SHBAJRGShri Bajrang Alliance Limited
SHBAJRG
-
300801
-
688136